Clinical Trial Update: Comparison of ddI Versus Zidovudine in HIV-Infected Patients [Phase 2]

View source ↗

Summary

A Phase 2 study comparing didanosine (ddi) versus zidovudine in HIV-infected patients has completed, reporting on comparative efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Didanosine (Videx) (didanosine)
• Zidovudine (Retrovir) (zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED